FURTHER CONFIRMATION OF MY HYPOTHESIS THAT THE SPIKE PROTEIN INDUCES A “DNA DISEASE”
THIS IS WHY THE YOUNG ARE INITIALLY LESS AFFECTED, HOWEVER THE DNA DAMAGE INDUCED BY THE SPIKE PROTEIN AGES THEM AT, (ACCORDING TO SOME MOUSE ALZHEIMER’S STUDIES) PERHAPS A SIX-FOLD RATE
The recent paper by UVM doctors (who are located less than two miles from me) confirms what I have been stating for two years. SARS-CoV-2 hijacks host cell genome instability pathways.
What is MOST important about this confirmation is that it supports and provides evidence for THE SOMATIC MUTATION THEORY OF AGING.
The somatic mutation theory of aging posits that the accumulation of mutations in the genetic material of somatic cells as a function of time results in a decrease in cellular function.
And this explains why the young are INITIALLY less affected by SARS-CoV-2 and the Spike Protein Therapies.
Induction of cellular senescence or apoptosis in response to DNA damage may function in this manner by preventing cancer in the young, but contributing to reduced tissue homeostasis in the old (Campisi, 2008).
Referenced/Related Papers
This is infinitely easier to read on substack than twitter.
What are your thoughts about the severe immune-mediated hepatitis outbreaks among young people that have been noted in diverse publications recently?
Very much interested in hearing your thoughts on this phenomenon.
Per the World Health Organization:
On 5 April 2022, WHO was notified of 10 cases of severe acute hepatitis of unknown aetiology in children under the age of 10 years, across central Scotland. By 8 April, 74 cases had been identified in the United Kingdom. Hepatitis viruses (A, B, C, E, and D where applicable) have been excluded after laboratory testing while further investigations are ongoing to understand the aetiology of these cases. Given the increase in cases reported over the past one month and enhanced case search activities, more cases are likely to be reported in the coming days.
On 5 April 2022, the International Health Regulations (IHR) National Focal Point (NFP) for the United Kingdom notified WHO of 10 cases of severe acute hepatitis of unknown aetiology in previously healthy young children (age range: 11 months to five-year-old) across central Scotland. Of these 10 cases, nine had onset of symptoms in March 2022 while one case had an onset of symptoms in January 2022. Symptoms included jaundice, diarrhoea, vomiting and abdominal pain. All 10 cases were detected when hospitalised.
As of 8 April 2022, further investigations across the United Kingdom have identified a total of 74 cases (including the 10 cases) fulfilling the case definition1. The clinical syndrome in identified cases is of acute hepatitis with markedly elevated liver enzymes, often with jaundice, sometimes preceded by gastrointestinal symptoms, in children principally up to 10 years old. Some cases have required transfer to specialist children’s liver units and six children have undergone liver transplantation. As of 11 April, no death has been reported among these cases and one epidemiologically linked case has been detected.
Laboratory testing has excluded hepatitis type A, B, C, and E viruses (and D where applicable) in these cases while Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and/or adenovirus have been detected in several cases. The United Kingdom has recently observed an increase in adenovirus activity, which is co-circulating with SARS-CoV-2, though the role of these viruses in the pathogenesis (mechanism by which disease develops) is not yet clear."
Also interesting is a letter to the editor which appears in the current J Hepatol (2022 vol 76, p 747). The letter is headlined "Immune mediated hepatitis with the Moderna vaccine, no longer a coincidence, but confirmed."
Very interested to hear your thoughts.